Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies

OBJECTIVE: Two recent non-interventional trials, GioTag and UpSwinG, demonstrated encouraging time-to-treatment failure (TTF) and overall survival (OS) in patients with epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) (Del19 or L858R) who received sequenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Satoru, Jung, Hyun Ae, Lee, Shin Yup, Lee, Seung Hyeun, Lee, Min Ki, Lee, Yong Chul, Hochmair, Maximilian J, Yang, Cheng-Ta, Märten, Angela, Yang, James Chih-Hsin, Popat, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416460/
https://www.ncbi.nlm.nih.gov/pubmed/36033903
http://dx.doi.org/10.2147/OTT.S362535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416460/
https://www.ncbi.nlm.nih.gov/pubmed/36033903
http://dx.doi.org/10.2147/OTT.S362535

Ejemplares similares